Tuberculosis Efforts

Lilly has a long and pioneering legacy in the fight against infectious diseases with the development of several important antibiotics, including two medicines that have been found to be effective for the treatment of multi-drug resistant tuberculosis (MDR-TB). Since 2003, we have built on these accomplishments to reduce suffering due to TB and MDR-TB and fund discovery efforts.

Learn More About Our Global TB Efforts